Cardiac Autonomic Dysfunction As a Sign of Irreversible Advanced Heart Failure
Recruiting · NCT06532825 · Observational (researchers observe without assigning treatment) · Lead sponsor: University Hospital Bispebjerg and Frederiksberg
View the official record on ClinicalTrials.gov →Interventions studied
What this trial is about
The main hypothesis is that autonomic dysfunction cannot improve among patients reaching end-stage heart failure. To evaluate this, patients admitted with acute decompensated heart failure in Bispebjerg hospital, and history one or more admissions with the same condition within the prior year, will undergo repeated brief heart monitoring (10 min). Baseline recordings (at admission) will be compared with equivalent measurements before discharge to explore whether heart rate variability increases. Patients will be followed for six months after discharge from the hospital.
Who can take part
Inclusion criteria
- 18-years age or older
- admitted with acute decompensated heart failure for less than 48 h
Exclusion criteria
- pacemaker
- not signed informed consent
- other heart rhythm than sinus rhythm or atrial fibrillation
Where it is running
1 location listed.
- Cardiology department Y, Bispebjerg-Frederiksberg Hospital - Frederiksberg, Denmark